Tech Company Financing Transactions

Millendo Therapeutics Funding Round

New Enterprise Associates, 5AM Ventures and Adams Street Partners participated in a $62 million Series B venture round for Millendo Therapeutics. The financing round was recorded on 1/4/2016.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series B
Proceeds Purpose
This acquisition of MLE4901 combined with the new funding and our current programs around ATR-101 puts us on a new trajectory to build a specialty pharmaceutical company focused on multiple disease-modifying treatments for endocrine disorders caused by hormone dysregulation.

Company Information

Company Status
Private & Independent
Mailing Address
110 Miller Ave. 100
Ann Arbor, MI 48104
Email Address
Millendo Therapeutics is focused on developing a portfolio of disease-modifying treatments for endocrine disorders caused by hormone dysregulation. Our product candidates seek to improve the quality of life for patients with orphan and specialty diseases with limited or no approved treatment options.
Millendo Therapeutics LinkedIn Company Profile
Social Media
Millendo Therapeutics Company Twitter Account
Company News
Millendo Therapeutics News
Millendo Therapeutics on Facebook
Millendo Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Julia Owens
  Julia Owens LinkedIn Profile  Julia Owens Twitter Account  Julia Owens News  Julia Owens on Facebook
Chief Financial Officer
Louis Arcudi
  Louis Arcudi LinkedIn Profile  Louis Arcudi Twitter Account  Louis Arcudi News  Louis Arcudi on Facebook
Chief Medical Officer
Christophe Arbet-Engels
  Christophe Arbet-Engels LinkedIn Profile  Christophe Arbet-Engels Twitter Account  Christophe Arbet-Engels News  Christophe Arbet-Engels on Facebook
VP - Bus. Development
Thomas Hoover
  Thomas Hoover LinkedIn Profile  Thomas Hoover Twitter Account  Thomas Hoover News  Thomas Hoover on Facebook
VP - Bus. Development
Ryan Zeidan
  Ryan Zeidan LinkedIn Profile  Ryan Zeidan Twitter Account  Ryan Zeidan News  Ryan Zeidan on Facebook
VP - General Counsel
Tamara Joseph
  Tamara Joseph LinkedIn Profile  Tamara Joseph Twitter Account  Tamara Joseph News  Tamara Joseph on Facebook



Browse more venture capital transactions:

Prev: 1/4/2016: Front Desk venture capital transaction
Next: 1/4/2016: Degreed venture capital transaction


Share this article


Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary